Ionis Pharmaceuticals, Inc. · NASDAQ:IONS

T. Rowe Price Investment Management, Inc. reported a 8.30% stake in Ionis Pharmaceuticals, Inc. (Schedule 13G/A)

Event Sep 30, 2025 · Filed Nov 14, 2025

T. Rowe Price Investment Management, Inc. reported a 8.30% stake in Ionis Pharmaceuticals, Inc., 13,157,114 shares, as a passive investor on Sep 30, 2025. Filed Nov 14, 2025 (Schedule 13G/A).

Stake
8.30%
Shares
13,157,114
Intent
Passive
What changed
Stake changed

The filing in full

HolderStakeShares
T. Rowe Price Investment Management, Inc.8.30%13,157,114

Source

View original at SEC

Related